Analysis of the available RNA-seq data showed that the T-ALL tumour with the LMO1 enhancer mutation had the sixth highest expression level of LMO1 relative to the 264 T-ALLs analysed in the NCI TARGET (Figure 2c), consistent with the cancer cell line data (Figure 1a). The gene discussed is LMO1; the disease is neoplasm.